ArticleBritish journal of pharmacology2002
Effects of FPL 64176 on Ca transients in voltage-clamped rat ventricular myocytes.
Article in British journal of pharmacology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Cardiac Rhythm and Molecular Docking Studies of Ion Channel Ligands with Cardiotoxicity in Zebrafish.Cells · 2019Article
- Cinnamomi ramulus Ethanol Extract Exerts Vasorelaxation through Inhibition of Ca Influx and Ca Release in Rat Aorta.Evidence-based complementary and alternative medicine : eCAM · 2012Article
- Acute atrial arrhythmogenesis in murine hearts following enhanced extracellular Ca(2+) entry depends on intracellular Ca(2+) stores.Acta physiologica (Oxford, England) · 2010Article
- Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts.Experimental physiology · 2009Article
- FPL-64176 alters both charge movement and Ca2+ release properties in amphibian muscle fibres.Pflugers Archiv : European journal of physiology · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 3 countries.
Funding
Abstract
1. The L-type Ca channel agonist FPL 64176 increased the amplitude of both Ca currents and Ca transients elicited from isolated voltage clamped rat ventricular myocytes far more than it increased the rate of rise of the Ca transients. Consequently, the gain function relating the amplitude of peak Ca current to Ca transient rate of rise was greatly reduced at all potentials. 2. Furthermore, an increase in this gain function normally observed at negative potentials is abolished by FPL 64716. 3. Despite slowing the rate of decline of Ca transients, FPL 64176, at the concentration of 1 microM used throughout, had no direct effect on sarcoplasmic reticulum (SR) Ca uptake or release using isolated cardiac membranes. 4. Arguments based on results presented here and elsewhere suggest that decreased gain was not due to increased ryanodine receptor adaptation or inactivation, to decreased L-type single channel current, to decreased SR Ca content, or to decreased synchronization of release. Decreased gain instead appears to reflect a form of decrease in coupling efficiency due either to differential effects of long openings on whole cell currents as opposed to the Ca release the long openings trigger or to some compensatory mechanism activated by the increased Ca trigger or resting free [Ca(2+)](i). 5. Abolition by FPL 64176 of the increased gain normally seen at negative potentials rendered it impossible to confirm or refute the claim that a single Ca ion suffices to activate ryanodine receptors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.